VILBETES 50MG TAB

Distributor inventory | Tablet

Type 2 diabetes mellitus (to improve glycaemic control) as monotherapy or in combination with other antidiabetic medicines (e.g., metformin, sulfonylurea, insulin) along with diet and exercise.

Vildagliptin is a DPP-4 inhibitor that increases levels of incretin hormones (GLP-1 and GIP). This enhances glucose-dependent insulin secretion and reduces glucagon release, helping lower blood glucose with a low risk of hypoglycaemia when used alone.

Tablet for oral use. Take exactly as prescribed by the doctor, usually once or twice daily. Can be taken with or without food; take at the same time each day and continue diet/exercise plan. Do not double the dose if a dose is missed.

Headache,dizziness,nausea,diarrhoea,abdominal pain,constipation,upper respiratory tract infection,back pain,peripheral oedema,skin rash

Not for type 1 diabetes or diabetic ketoacidosis. Use with caution in liver disease; liver function tests may be needed before and during treatment—stop and seek care if jaundice/dark urine occurs. Use caution in renal impairment and in elderly; dose adjustment may be required based on kidney function. Rare risk of pancreatitis—seek medical help for severe persistent abdominal pain. If used with sulfonylurea/insulin, risk of hypoglycaemia may increase. Inform doctor about history of heart failure; monitor for fluid retention/shortness of breath.

Insulin and sulfonylureas (increased risk of hypoglycaemia),ACE inhibitors (rare increased risk of angioedema),other antidiabetic drugs (additive glucose-lowering effect); clinically significant CYP interactions are unlikely.

Store below 25°C in a dry place, protected from moisture and light. Keep in original blister pack and out of reach of children.

Galvus 50 Tablet,Jalra 50 Tablet,Zomelis 50 Tablet,Vilda 50 Tablet,Vildapin 50 Tablet